1. Invitro activity of new sulphanilil fluoroquinolones against Staphylococcus aureus;Allemandi;J. Antimicrob. Chemother.,1994
2. Engineering the specificity of antibacterial fluoroquinolones: benzenesulfonamide modifications at C-7 of ciprofloxacin change its primary target in Streptococcus pneumonia from topoisomerase IV to gyrase;Alovero;Antimicrob. Agents Chemother.,2000
3. Amano , H. N. Hayashi Y. Ohshita Y. Niino A. Yazaki 1997 WQ-2724 and WQ-2743, Novel fluoroquinolones: in vitro and in vivo activities, pharmacokinetics and toxicity
4. The fluoroquinolone antibacterials: past, present, and future perspectives;Applebaum;Int. J. Antibacter. Agents,2000
5. Armiger , Y. L. D. T. W. Chu A. K. L. Fung Q. Li W. Wang A. Nilius J. Alder P. Ewing G. Stone J. Meulbroek M. Bui L. L. Shen L. Paige Y. S. Or J. J. Plattner 1998 The discovery of A-165753 and 170568, two potent broad spectrum antimicrobial agents, abstr. F-86 In Proceedings of the 38th Interscience Conference on Antimicrobial Agents and Chemotherapy